ConductScience.org, home

Paper40468398

New discoveries in therapeutic targets and drug development pathways for type 2 diabetes mellitus under the guidance of precision medicine.

Tian X and 9 others. Eur J Med Res, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. New discoveries in therapeutic targets and drug development pathways for type 2 diabetes mellitus under the guidance of precision medicine. Papers, record 40468398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40468398

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New discoveries in therapeutic targets and drug development pathways for type 2 diabetes mellitus under the guidance of precision medicine.
PubMed
Journal
Eur J Med Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
3.05, provisional
iCite
Revised in PubMed
2025-06-09
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tian XXinyi
2Wang LLiuqing
3Zhang LLu
4Chen XXiao
5Wang WWenjun
6Zhang KKaiqi
7Ge XXiaolei
8Luo ZZhengrong
9Zhai XXu
10Shao HHuaqiang

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Precision MedicineMajor topic
Drug DevelopmentMajor topic
Hypoglycemic AgentsMajor topic
Humans
Gastrointestinal Microbiome
Molecular Targeted Therapy
Animals

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BJZYYB-2023-28Fundamental Research Funds for the China Academy of Chinese Medical SciencesPubMed

Source PubMed

Download CSV of grants

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139037913Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity.Elife2024https://conductscience.org/library/papers/39037913PubMed
215487979Psychological barriers.Eur J Endocrinol2004https://conductscience.org/library/papers/15487979PubMed
333463546Pharmacological treatment of hyperglycemia in type 2 diabetes.J Clin Invest2021https://conductscience.org/library/papers/33463546PubMed
430760847Function and mechanisms of enteroendocrine cells and gut hormones in metabolism.Nat Rev Endocrinol2019https://conductscience.org/library/papers/30760847PubMed
532872570Pathophysiology of Type 2 Diabetes Mellitus.Int J Mol Sci2020https://conductscience.org/library/papers/32872570PubMed
639059739Proteomics profiling and association with cardiorenal complications in type 2 diabetes subtypes in Asian population.Diabetes Res Clin Pract2024https://conductscience.org/library/papers/39059739PubMed
730672723In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion.Nucleic Acid Ther2019https://conductscience.org/library/papers/30672723PubMed
831623194Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges.Int J Mol Sci2019https://conductscience.org/library/papers/31623194PubMed
934579087Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.Nutrients2021https://conductscience.org/library/papers/34579087PubMed
1037033254Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37033254PubMed
1133125843Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes.J Med Chem2020https://conductscience.org/library/papers/33125843PubMed
1238095657
Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.
Diabetologia2024https://conductscience.org/library/papers/38095657PubMed
1335982037Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota.Nat Commun2022https://conductscience.org/library/papers/35982037PubMed
1436342518Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.Diabetes2023https://conductscience.org/library/papers/36342518PubMed
1531424428β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes.J Clin Invest2019https://conductscience.org/library/papers/31424428PubMed
1637543292MicroRNA biomarkers target genes and pathways associated with type 2 diabetes.Diabetes Res Clin Pract2023https://conductscience.org/library/papers/37543292PubMed
1735484823A GLP-1/glucagon (GCG)/CCK2 receptors tri-agonist provides new therapy for obesity and diabetes.Br J Pharmacol2022https://conductscience.org/library/papers/35484823PubMed
1836332637Type 2 diabetes.Lancet2022https://conductscience.org/library/papers/36332637PubMed
1932556613Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetologia2020https://conductscience.org/library/papers/32556613PubMed
2038891870MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program.Int J Mol Sci2024https://conductscience.org/library/papers/38891870PubMed

See all 76 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42958439Inflammatory networks between adipose tissue, liver and pancreatic islets in type 2 diabetes.Hum Genomics2026https://conductscience.org/library/papers/42958439PubMed
42703356Association Between the Triglyceride-Glucose Index and Clinical Outcomes Modified by Diabetes Duration in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus.Diabetes Metab Syndr Obes2026https://conductscience.org/library/papers/42703356PubMed
41752213Photobiomodulation and Low-Level Laser Therapy as Complementary Strategies in Diabetes Treatment.Int J Mol Sci2026https://conductscience.org/library/papers/41752213PubMed
41599783Emerging Breakthroughs in Nano-Ginseng Innovations and Their Therapeutic Implications in Type 2 Diabetes.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41599783PubMed
41517974PGC-1α Transcriptionally Regulated by ChREBP Mitigates Neuropathic Pain Through Promoting Microglial Fatty Acid Oxidation and Anti-Inflammatory Response.CNS Neurosci Ther2026https://conductscience.org/library/papers/41517974PubMed
40919563Research Progress of Mitochondrial Dynamics and Autophagy in Diabetic Complications: New Treatment Strategies.Diabetes Metab Syndr Obes2025https://conductscience.org/library/papers/40919563PubMed
40565232Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions.Int J Mol Sci2025https://conductscience.org/library/papers/40565232PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
MLXIP22877PubTator's text mininghttps://conductscience.org/library/genes/22877NCBI Gene
MLXIPL51085PubTator's text mininghttps://conductscience.org/library/genes/51085NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40468398

GET https://conductscience.org/api/papers/v1/40468398/references?page=2